# A Study of GDC-0941 in Participants With Locally Advanced or Metastatic Solid Tumors for Which Standard Therapy Either Does Not Exist or Has Proven Ineffective or Intolerable

> **NCT00876109** · PHASE1 · COMPLETED · sponsor: **Genentech, Inc.** · enrollment: 108 (actual)

## Conditions studied

- Solid Cancers

## Interventions

- **DRUG:** GDC-0941

## Key facts

- **NCT ID:** NCT00876109
- **Lead sponsor:** Genentech, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2012-06
- **Final completion:** 2013-11
- **Target enrollment:** 108 (ACTUAL)
- **Last updated:** 2016-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00876109

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00876109, "A Study of GDC-0941 in Participants With Locally Advanced or Metastatic Solid Tumors for Which Standard Therapy Either Does Not Exist or Has Proven Ineffective or Intolerable". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00876109. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*